ScatizziA., StrippoliP.Prevention of Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis. In: SmebyL.C., JorstadS., WideroeT.E., eds. Immune and metabolic aspects of therapeutic blood purification systems.Basel: Karger, 1986: 191–6.
2.
StrippoliP., CovielloF., OrbelloG., ScatizziA.Long-term experience with antistaphylococcal vaccination in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) (Abstract).Blood Purif1987; 5: 312.
3.
KimK.S., ParkM.S., HwangS.D., LeeH.B.The prevention of staphylococcal peritonitis in CAPD patients (Abstract).Kidney Int1989; 36: 1189.
4.
Poole-WarrenL.A., HallettM.D., HoneP.W., BurdenS.H., FarrellP.C.Vaccination for the prevention of CAPD-associated staphylococcal infection: Results of a prospective multicentre clinical trial.Clin Nephrol1991; 35: 198–206.
5.
FosterT.J.Potential for vaccination against infections caused by Staphylococcus aureus.Vaccine1991; 9: 221–7.
6.
SmithD.G.E., WilcoxM.H., WilliamsP., FinchR.G., DenyerS.P.Characterisation of cell envelope proteins of Staphylococcus epidermidis cultured in human peritoneal dialysate.Infect Immun1991; 59: 617–24.
7.
SpencerR.C.Infection in continuous ambulatory peritoneal dialysis.J Med Microbiol1988; 27: 1–9.
8.
San ClementeC.L.Serologic and clinical reaction in cows to staphylococcus antigens.Am J Vet Res1970; 31: 643–51.
9.
YokomizoY., IsayomaY.The characteristics of antibacterial antibodies in bovine immune sera to Staphylo coccus aureus.Microbiol Immunol1978; 22: 1–13.
10.
LeeJ.C., Bet leyM.J., HopkinsC.A., PerezN.E., PierG.B.Virulence studies in mice of transposon-induced mutants of Staphylococcus aureus differing in capsule size.J Infect Dis1988; 157: 723–30.
FattomA., SchneersonR., SzuS.C.Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A.Infect Immun1990; 58: 2367.
13.
WilcoxM.H., WilliamsP., SmithD.G.E., ModunB., FinchR.G., DenyerS.P.Variation in the expression of cell envelope proteins of coagulase-negative staphylococci cultured under iron-restricted conditions in human peritoneal dialysate.J GenMicrobiol1991; 137: 2561–70.
14.
ZorzetsZ., ZorzetsA., GolonE., ZevinD., BernheimJ.CAPD peritonitis-initial presentation as an acute abdomen with clear peritoneal fluid.Clin Nephrol1992; 37: 155–7.
15.
ZimmerliW., LewP.D., WaldovelF.A.Pathogenesis of foreign body infection. Evidence for a local granulocyte defect.J Clin Invest1984; 73: 1191–200.
16.
FlemingS.J., MoranD.M., CooksleyW.G., FaoagoliJ.L.Poor response to a recombinant hepatitis B vaccine in dialysis patients.J Infect1991; 22: 251–7.
17.
ChurchillD.N., TaylorD.W., VasS.I.Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): A multicenter randomized clinical trial comparing the Y-connector disinfectant system to standard systems.Perit Dial Int1989; 9: 159–63.
18.
DrydenM.S., McCannM., WingA.J., PhillipsI.Controlled trial of a Y-set dialysis delivery system to prevent peritonitis in patients receiving continuous ambulatory peritoneal dialysis.J Hosp Infect1992; 20: 185–92.
19.
SwartzR., MessanaJ., StarmannB., WeberM., ReynoldsJ.Preventing Staphylococcus aureus infection during chronic peritoneal dialysis.J Am Soc Nephrol1991; 2: 1085–91.